Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure
Background Vitamin D is a fat-soluble hormone necessary for calcium homeostasis. Recently, studies have demonstrated that vitamin D may be important to the health of the cardiovascular system. Methods Adults ≥50 years of age with heart failure were recruited for assessment of serum 25-hydroxyvitamin...
Gespeichert in:
Veröffentlicht in: | The American heart journal 2010-11, Vol.160 (5), p.893-899 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 899 |
---|---|
container_issue | 5 |
container_start_page | 893 |
container_title | The American heart journal |
container_volume | 160 |
creator | Boxer, Rebecca S., MD Kenny, Anne M., MD Cheruvu, Vinay K., MSc, MS Vest, Marianne, MA, BSN, RN Fiutem, Justin J., MS, RCEP Piña, Ileana I., MD, MPH |
description | Background Vitamin D is a fat-soluble hormone necessary for calcium homeostasis. Recently, studies have demonstrated that vitamin D may be important to the health of the cardiovascular system. Methods Adults ≥50 years of age with heart failure were recruited for assessment of serum 25-hydroxyvitamin D (25OHD) concentrations. Cardiopulmonary exercise testing was used to assess functional capacity. Proximal muscle strength was evaluated with a Biodex leg press (Biodex, Shirley, NY), and health status was assessed with the Kansas City Cardiomyopathy Questionnaire. Univariate associations between physical performance and health status measures and 25OHD followed by a linear regression model were used to study associations, adjusting for other potential explanatory variables. Results Forty adults 67.8 ± 10.9 years of age (55% women and 57.5% African American) with mean ejection fraction 40% were analyzed (New York Heart Association class II in 70% and class III in 30%). Comorbidities included 77.5% hypertension and 47.5% diabetes. The mean 25OHD concentration was 18.5 ± 9.1 ng/mL, and mean peak V o2 , 14 ± 4 mL/kg/min. In univariate regression analysis, 25OHD was positively associated with peak V o2 ( P = .045). Multivariable regression analysis sustained positive association between 25OHD and peak V o2 ( P = .044) after adjusting for age, race, and respiratory exchange ratio (adjusted R2 = 0.32). Association between proximal muscle strength with the 25OHD concentration was not significant. The Kansas City Cardiomyopathy Questionnaire physical limitation domain score was negatively associated with 25OHD ( P = .04) but was not sustained in multivariable analysis. Conclusions 25-Hydroxyvitamin D may be an important marker or modulator of functional capacity in patients with heart failure. Randomized controlled trials are needed to assess the effect of vitamin D repletion on functional performance. |
doi_str_mv | 10.1016/j.ahj.2010.08.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2998064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870310006782</els_id><sourcerecordid>3238416351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-da3f44de49e3a80f5f5ec75971a5747a4ee4582d365f3d883ac63e67dc07a62f3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEokvhB3BBlhDHLI7t2ImQKqHyKVXiUDhbgz0hXrLx1nYW8u9xlKUFDpys0TzzzozfKYqnFd1WtJIvd1vod1tGc0ybLaXiXrGpaKtKqYS4X2wopaxsFOVnxaMYdzmUrJEPizOWqZoptSlurjFMe8Lqsp9t8D_no0uwdyN5Q4wfDY4pQHJ-JC4SiNEbBwkt-eFST7ppNEsOBmLgAMalmeRKP1gMBOw0pLiCPUJIpAM3TAEfFw86GCI-Ob3nxZd3bz9ffiivPr3_ePn6qjS15Km0wDshLIoWOTS0q7sajapbVUGthAKBKOqGWS7rjtum4WAkR6msoQok6_h5cbHqHqave7TrKoM-BLeHMGsPTv-dGV2vv_mjZm3bUCmywPOTQPA3E8akd34Keduoq5oKyfMsbaaqlTLBxxiwu-1QUb24pHc6u6QXlzRtdHYp1zz7c7Tbit-2ZODFCYBoYOgCjMbFO45LJhRbhF6tHOaPPDoMOhqH2TbrApqkrXf_HePin2ozuNHlht9xxni3rY5MU329nNNyTdVySKph_BdLGMbg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504639719</pqid></control><display><type>article</type><title>Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Boxer, Rebecca S., MD ; Kenny, Anne M., MD ; Cheruvu, Vinay K., MSc, MS ; Vest, Marianne, MA, BSN, RN ; Fiutem, Justin J., MS, RCEP ; Piña, Ileana I., MD, MPH</creator><creatorcontrib>Boxer, Rebecca S., MD ; Kenny, Anne M., MD ; Cheruvu, Vinay K., MSc, MS ; Vest, Marianne, MA, BSN, RN ; Fiutem, Justin J., MS, RCEP ; Piña, Ileana I., MD, MPH</creatorcontrib><description>Background Vitamin D is a fat-soluble hormone necessary for calcium homeostasis. Recently, studies have demonstrated that vitamin D may be important to the health of the cardiovascular system. Methods Adults ≥50 years of age with heart failure were recruited for assessment of serum 25-hydroxyvitamin D (25OHD) concentrations. Cardiopulmonary exercise testing was used to assess functional capacity. Proximal muscle strength was evaluated with a Biodex leg press (Biodex, Shirley, NY), and health status was assessed with the Kansas City Cardiomyopathy Questionnaire. Univariate associations between physical performance and health status measures and 25OHD followed by a linear regression model were used to study associations, adjusting for other potential explanatory variables. Results Forty adults 67.8 ± 10.9 years of age (55% women and 57.5% African American) with mean ejection fraction 40% were analyzed (New York Heart Association class II in 70% and class III in 30%). Comorbidities included 77.5% hypertension and 47.5% diabetes. The mean 25OHD concentration was 18.5 ± 9.1 ng/mL, and mean peak V o2 , 14 ± 4 mL/kg/min. In univariate regression analysis, 25OHD was positively associated with peak V o2 ( P = .045). Multivariable regression analysis sustained positive association between 25OHD and peak V o2 ( P = .044) after adjusting for age, race, and respiratory exchange ratio (adjusted R2 = 0.32). Association between proximal muscle strength with the 25OHD concentration was not significant. The Kansas City Cardiomyopathy Questionnaire physical limitation domain score was negatively associated with 25OHD ( P = .04) but was not sustained in multivariable analysis. Conclusions 25-Hydroxyvitamin D may be an important marker or modulator of functional capacity in patients with heart failure. Randomized controlled trials are needed to assess the effect of vitamin D repletion on functional performance.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2010.08.004</identifier><identifier>PMID: 21095277</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Aged ; Biological and medical sciences ; Biomarkers - blood ; Cardiology. Vascular system ; Cardiovascular ; Disease ; Double-Blind Method ; Exercise ; Exercise Test ; Exercise Tolerance - physiology ; Family medical history ; Female ; Follow-Up Studies ; Heart ; Heart attacks ; Heart failure ; Heart Failure - blood ; Heart Failure - drug therapy ; Heart Failure - physiopathology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Hospitals ; Humans ; Hypotheses ; Male ; Medical sciences ; Mens health ; Middle Aged ; Mineral oils ; Muscle Strength - physiology ; Older people ; Prognosis ; Regression analysis ; Severity of Illness Index ; Stroke Volume - physiology ; Surveys and Questionnaires ; Vitamin D ; Vitamin D - administration & dosage ; Vitamin D - analogs & derivatives ; Vitamin D - blood ; Vitamin D - pharmacokinetics ; Vitamin deficiency ; Vitamins - administration & dosage ; Vitamins - pharmacokinetics ; Womens health</subject><ispartof>The American heart journal, 2010-11, Vol.160 (5), p.893-899</ispartof><rights>Mosby, Inc.</rights><rights>2010 Mosby, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Mosby, Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Nov 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-da3f44de49e3a80f5f5ec75971a5747a4ee4582d365f3d883ac63e67dc07a62f3</citedby><cites>FETCH-LOGICAL-c563t-da3f44de49e3a80f5f5ec75971a5747a4ee4582d365f3d883ac63e67dc07a62f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1504639719?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27929,27930,46000,64390,64394,72474</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23624724$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21095277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boxer, Rebecca S., MD</creatorcontrib><creatorcontrib>Kenny, Anne M., MD</creatorcontrib><creatorcontrib>Cheruvu, Vinay K., MSc, MS</creatorcontrib><creatorcontrib>Vest, Marianne, MA, BSN, RN</creatorcontrib><creatorcontrib>Fiutem, Justin J., MS, RCEP</creatorcontrib><creatorcontrib>Piña, Ileana I., MD, MPH</creatorcontrib><title>Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Background Vitamin D is a fat-soluble hormone necessary for calcium homeostasis. Recently, studies have demonstrated that vitamin D may be important to the health of the cardiovascular system. Methods Adults ≥50 years of age with heart failure were recruited for assessment of serum 25-hydroxyvitamin D (25OHD) concentrations. Cardiopulmonary exercise testing was used to assess functional capacity. Proximal muscle strength was evaluated with a Biodex leg press (Biodex, Shirley, NY), and health status was assessed with the Kansas City Cardiomyopathy Questionnaire. Univariate associations between physical performance and health status measures and 25OHD followed by a linear regression model were used to study associations, adjusting for other potential explanatory variables. Results Forty adults 67.8 ± 10.9 years of age (55% women and 57.5% African American) with mean ejection fraction 40% were analyzed (New York Heart Association class II in 70% and class III in 30%). Comorbidities included 77.5% hypertension and 47.5% diabetes. The mean 25OHD concentration was 18.5 ± 9.1 ng/mL, and mean peak V o2 , 14 ± 4 mL/kg/min. In univariate regression analysis, 25OHD was positively associated with peak V o2 ( P = .045). Multivariable regression analysis sustained positive association between 25OHD and peak V o2 ( P = .044) after adjusting for age, race, and respiratory exchange ratio (adjusted R2 = 0.32). Association between proximal muscle strength with the 25OHD concentration was not significant. The Kansas City Cardiomyopathy Questionnaire physical limitation domain score was negatively associated with 25OHD ( P = .04) but was not sustained in multivariable analysis. Conclusions 25-Hydroxyvitamin D may be an important marker or modulator of functional capacity in patients with heart failure. Randomized controlled trials are needed to assess the effect of vitamin D repletion on functional performance.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Disease</subject><subject>Double-Blind Method</subject><subject>Exercise</subject><subject>Exercise Test</subject><subject>Exercise Tolerance - physiology</subject><subject>Family medical history</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - physiopathology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mens health</subject><subject>Middle Aged</subject><subject>Mineral oils</subject><subject>Muscle Strength - physiology</subject><subject>Older people</subject><subject>Prognosis</subject><subject>Regression analysis</subject><subject>Severity of Illness Index</subject><subject>Stroke Volume - physiology</subject><subject>Surveys and Questionnaires</subject><subject>Vitamin D</subject><subject>Vitamin D - administration & dosage</subject><subject>Vitamin D - analogs & derivatives</subject><subject>Vitamin D - blood</subject><subject>Vitamin D - pharmacokinetics</subject><subject>Vitamin deficiency</subject><subject>Vitamins - administration & dosage</subject><subject>Vitamins - pharmacokinetics</subject><subject>Womens health</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kk1v1DAQhiMEokvhB3BBlhDHLI7t2ImQKqHyKVXiUDhbgz0hXrLx1nYW8u9xlKUFDpys0TzzzozfKYqnFd1WtJIvd1vod1tGc0ybLaXiXrGpaKtKqYS4X2wopaxsFOVnxaMYdzmUrJEPizOWqZoptSlurjFMe8Lqsp9t8D_no0uwdyN5Q4wfDY4pQHJ-JC4SiNEbBwkt-eFST7ppNEsOBmLgAMalmeRKP1gMBOw0pLiCPUJIpAM3TAEfFw86GCI-Ob3nxZd3bz9ffiivPr3_ePn6qjS15Km0wDshLIoWOTS0q7sajapbVUGthAKBKOqGWS7rjtum4WAkR6msoQok6_h5cbHqHqave7TrKoM-BLeHMGsPTv-dGV2vv_mjZm3bUCmywPOTQPA3E8akd34Keduoq5oKyfMsbaaqlTLBxxiwu-1QUb24pHc6u6QXlzRtdHYp1zz7c7Tbit-2ZODFCYBoYOgCjMbFO45LJhRbhF6tHOaPPDoMOhqH2TbrApqkrXf_HePin2ozuNHlht9xxni3rY5MU329nNNyTdVySKph_BdLGMbg</recordid><startdate>20101101</startdate><enddate>20101101</enddate><creator>Boxer, Rebecca S., MD</creator><creator>Kenny, Anne M., MD</creator><creator>Cheruvu, Vinay K., MSc, MS</creator><creator>Vest, Marianne, MA, BSN, RN</creator><creator>Fiutem, Justin J., MS, RCEP</creator><creator>Piña, Ileana I., MD, MPH</creator><general>Mosby, Inc</general><general>Mosby</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20101101</creationdate><title>Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure</title><author>Boxer, Rebecca S., MD ; Kenny, Anne M., MD ; Cheruvu, Vinay K., MSc, MS ; Vest, Marianne, MA, BSN, RN ; Fiutem, Justin J., MS, RCEP ; Piña, Ileana I., MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-da3f44de49e3a80f5f5ec75971a5747a4ee4582d365f3d883ac63e67dc07a62f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Disease</topic><topic>Double-Blind Method</topic><topic>Exercise</topic><topic>Exercise Test</topic><topic>Exercise Tolerance - physiology</topic><topic>Family medical history</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - physiopathology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mens health</topic><topic>Middle Aged</topic><topic>Mineral oils</topic><topic>Muscle Strength - physiology</topic><topic>Older people</topic><topic>Prognosis</topic><topic>Regression analysis</topic><topic>Severity of Illness Index</topic><topic>Stroke Volume - physiology</topic><topic>Surveys and Questionnaires</topic><topic>Vitamin D</topic><topic>Vitamin D - administration & dosage</topic><topic>Vitamin D - analogs & derivatives</topic><topic>Vitamin D - blood</topic><topic>Vitamin D - pharmacokinetics</topic><topic>Vitamin deficiency</topic><topic>Vitamins - administration & dosage</topic><topic>Vitamins - pharmacokinetics</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boxer, Rebecca S., MD</creatorcontrib><creatorcontrib>Kenny, Anne M., MD</creatorcontrib><creatorcontrib>Cheruvu, Vinay K., MSc, MS</creatorcontrib><creatorcontrib>Vest, Marianne, MA, BSN, RN</creatorcontrib><creatorcontrib>Fiutem, Justin J., MS, RCEP</creatorcontrib><creatorcontrib>Piña, Ileana I., MD, MPH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boxer, Rebecca S., MD</au><au>Kenny, Anne M., MD</au><au>Cheruvu, Vinay K., MSc, MS</au><au>Vest, Marianne, MA, BSN, RN</au><au>Fiutem, Justin J., MS, RCEP</au><au>Piña, Ileana I., MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2010-11-01</date><risdate>2010</risdate><volume>160</volume><issue>5</issue><spage>893</spage><epage>899</epage><pages>893-899</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Background Vitamin D is a fat-soluble hormone necessary for calcium homeostasis. Recently, studies have demonstrated that vitamin D may be important to the health of the cardiovascular system. Methods Adults ≥50 years of age with heart failure were recruited for assessment of serum 25-hydroxyvitamin D (25OHD) concentrations. Cardiopulmonary exercise testing was used to assess functional capacity. Proximal muscle strength was evaluated with a Biodex leg press (Biodex, Shirley, NY), and health status was assessed with the Kansas City Cardiomyopathy Questionnaire. Univariate associations between physical performance and health status measures and 25OHD followed by a linear regression model were used to study associations, adjusting for other potential explanatory variables. Results Forty adults 67.8 ± 10.9 years of age (55% women and 57.5% African American) with mean ejection fraction 40% were analyzed (New York Heart Association class II in 70% and class III in 30%). Comorbidities included 77.5% hypertension and 47.5% diabetes. The mean 25OHD concentration was 18.5 ± 9.1 ng/mL, and mean peak V o2 , 14 ± 4 mL/kg/min. In univariate regression analysis, 25OHD was positively associated with peak V o2 ( P = .045). Multivariable regression analysis sustained positive association between 25OHD and peak V o2 ( P = .044) after adjusting for age, race, and respiratory exchange ratio (adjusted R2 = 0.32). Association between proximal muscle strength with the 25OHD concentration was not significant. The Kansas City Cardiomyopathy Questionnaire physical limitation domain score was negatively associated with 25OHD ( P = .04) but was not sustained in multivariable analysis. Conclusions 25-Hydroxyvitamin D may be an important marker or modulator of functional capacity in patients with heart failure. Randomized controlled trials are needed to assess the effect of vitamin D repletion on functional performance.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>21095277</pmid><doi>10.1016/j.ahj.2010.08.004</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 2010-11, Vol.160 (5), p.893-899 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2998064 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
subjects | Aged Biological and medical sciences Biomarkers - blood Cardiology. Vascular system Cardiovascular Disease Double-Blind Method Exercise Exercise Test Exercise Tolerance - physiology Family medical history Female Follow-Up Studies Heart Heart attacks Heart failure Heart Failure - blood Heart Failure - drug therapy Heart Failure - physiopathology Heart failure, cardiogenic pulmonary edema, cardiac enlargement Hospitals Humans Hypotheses Male Medical sciences Mens health Middle Aged Mineral oils Muscle Strength - physiology Older people Prognosis Regression analysis Severity of Illness Index Stroke Volume - physiology Surveys and Questionnaires Vitamin D Vitamin D - administration & dosage Vitamin D - analogs & derivatives Vitamin D - blood Vitamin D - pharmacokinetics Vitamin deficiency Vitamins - administration & dosage Vitamins - pharmacokinetics Womens health |
title | Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T05%3A37%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%2025-hydroxyvitamin%20D%20concentration%20is%20associated%20with%20functional%20capacity%20in%20older%20adults%20with%20heart%20failure&rft.jtitle=The%20American%20heart%20journal&rft.au=Boxer,%20Rebecca%20S.,%20MD&rft.date=2010-11-01&rft.volume=160&rft.issue=5&rft.spage=893&rft.epage=899&rft.pages=893-899&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2010.08.004&rft_dat=%3Cproquest_pubme%3E3238416351%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504639719&rft_id=info:pmid/21095277&rft_els_id=S0002870310006782&rfr_iscdi=true |